AI eye exam: could a computer beat your doctor at spotting diabetic blindness?
NCT ID NCT04132401
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an artificial intelligence (AI) algorithm to detect diabetic retinopathy and glaucoma from eye photos. Researchers compared the AI's accuracy to that of family doctors and retina specialists. The goal was to see if AI could be a reliable screening tool in primary care for people with diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Artificial intelligence algorithm
What this could lead to
If successful, this AI could help screen for diabetic eye disease more quickly and accurately in primary care, potentially preventing blindness.
What could go wrong
This is a completed study comparing AI to doctors, not a treatment trial. The AI may not perform as well in real-world settings or with different patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- THN391 for Diabetic Macular Edema Trial NCT06701721
- Smartphone Screening for Eye Diseases - NCT03076697
- VIEW II: Community Eye Screening Trial (NCT03752840)
- Biomarker of Diabetic Retinopathy Study | NCT05079399
- APX3330 for Diabetic Retinopathy Trial (NCT04692688)
- N-Acetyl Cysteine for Diabetic Retinopathy | NCT07634991
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CAP Bages
Manresa, Barcelona, 08242, Spain